Wendling, Daniel
Prati, Clément
Article History
First Online: 23 February 2017
Competing interests
: D.W. declares that he has received speaking fees from, acted as an adviser for or received hospitality from AbbVie, Amgen, BMS, Celgene, Chugai, Eli Lilly, Hospira, Janssen, MSD, Nordic Pharma, Novartis, Pfizer, Roche, Sandoz, Sanofi Aventis, SOBI and UCB. C.P. declares that he has received speaking fees from, acted as an adviser for or received hospitality from BMS, Chugai, Eli Lilly, Hospira, Janssen, Medac, Novartis, Pfizer, Roche and UCB.